A step forward: Translational Andrology and Urology is indexed in PubMed/PMC

By December 5^th, 2015, the Translational Andrology and Urology (TAU) has passed all the evaluation required by PubMed Central (PMC) and is officially accepted for inclusion in PubMed/PMC—an extensive and important biomedical online journal repository. All previously published content on TAU will be searchable within 1–2 months. Consequently, authors publishing in TAU will enjoy maximum exposure of their research. Acceptance in this prominent database speaks highly to the quality of the published work and the journal’s significant potential. TAU would like to express sincere appreciation for the enthusiastic and vigorous support and contributions from all board members, guest editors, reviewers, authors, and readers.

Launched in March 2012, Translational Andrology and Urology (http://tau.amegroups.com) is a peer-reviewed, open-access international journal dedicating to the fields of translational andrology and urology. It was quarterly published from 2012 to 2014 and has been bi-monthly published since 2015.

Twenty-one issues have been published from March 2012 to December 2015. Among them, three are supplement issues and 11 are focused issues concentrating on hot topics. These Focused Issues were guest-edited by leading experts in the field (Table 1). Considering that Focused Issues would benefit readers more intensively, TAU is planning to publish more in the future (Table 2).

Table 1. Focused Issues published on Translational Andrology and Urology.

Vol, issue	Topic	Guest Editor(s)	Affiliation
V2N1	Men’s Health	Run Wang	University of Texas Medical School at Houston and MD Anderson Cancer Center, USA
V2N3	Prostate Cancer	Jer-Tsong Hsieh Ganesh Raj	University of Texas Southwestern Medical Center at Dallas, USA
V3N1	Male infertility, Microsurgery and Men’s Health	Philip S. Li Marc Goldstein	Weill Cornell Medical College, USA
V3N2	Male Genitourinary Reconstruction and Trauma	Benjamin N. Breyer Jack W. McAninch	University of California San Francisco, USA
V3N3	Kidney Stone Disease	Thomas Chi Marshall L. Stoller	University of California San Francisco, USA
V3N4	Pediatric Urology	Laurence S. Baskin Barry A. Kogan	UCSF Children’s Hospital Albany Medical College, USA
V4N1	Contemporary Management of Urethral Stricture	Jay Simhan Allen F. Morey	Fox Chase/Einstein Urologic Institute University of Texas Southwestern Medical Center, USA
V4N2	Cancer and Sexual Health	Luca Incrocci	Erasmus MC Cancer Institute, The Netherlands
V4N3	Urological Oncology	George N. Thalmann	University Hospital of Bern, Switzerland
V4N5	Interstitial Cystitis/Painful Bladder Syndrome	Grannum R. Sant	Tufts University School of Medicine, USA
V4N6	Interstitial Cystitis/Painful Bladder Syndrome	Ricardo Saban	University Anhembi Morumbi, Brazil

Table 2. Focused Issues to be published on Translational Andrology and Urology.

Topic	Guest Editor(s)	Affiliation
Controversies and Current Management of Adult Neurogenic Bladder	Jeremy Myer	University of Utah, USA
	Sean Elliot	University of Minnesota, USA
	John Stoffl	University of Michigan Health System, USA
	Blayne Welk	Western University, Canada
Current Topics in Men’s Health	Charles Welliver	Albany Medical College, USA
	Tobias Köhler	Southern Illinois University School of Medicine, USA
	Kevin McVary
Urothelial Carcinoma	Shahrokh F. Sharia	Vienna General Hospital, Medical University of Vienna, Austria
	Romain Mathieu
Ejaculatory Dysfunction	Chris G. McMahon	Australian Centre for Sexual Health, Sydney, Australia
Peyronie’s Disease	Wayne J.G. Hellstrom	Tulane University School of Medicine, USA
	Faysal A. Yafi
Genetic and Molecular Andrology	Yasushi Miyagawa	Osaka University Graduate School of Medicine, Japan

The journal aims to become a forum for basic researchers and clinicians to share research findings and clinical solutions, to identify new translational enterprises, and to shape future directions for basic research and clinical practice in the field. In other words, the goal of TAU is to engage the public and facilitate translation of outstanding basic science and clinical research into excellent patient care in urology and andrology.

TAU has also been indexed in Scopus and endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).

TAU’s Publisher: AME Publishing Company

AME Publishing Company (www.amepc.org) is an international publisher of medical books and journals, who now owns more than 20 journals covering different fields of Medicine including oncology, pulmonology, cardiothoracic disease and urology. Each journal features peer-reviewed original contributions, comprehensive reviews, and editorials, as well as current case reports etc. AME Publishing Company have an integrated publishing system featuring a professional and highly efficient editorial team, to ensure that every part of our work from sending invitation to online publication goes as close-knit as following the assemble line, needless to say the robust electronic dissemination system for all our journals and articles. Currently, AME has 15 sister journals indexed by PubMed (PMC or MEDLINE). Seven journals indexed in Web of Science (WOS) [Science Citation Index Expended (SCIE) or Emerging Sources Citation Index (ESCI)]: specifically, three journals indexed by SCIE: Journal of Thoracic Disease, Chinese Journal of Cancer Research, and Translational Cancer Research; four journals indexed by ESCI/WOS: Annals of Cardiothoracic Surgery, Journal of Gastrointestinal Oncology, Cardiovascular Diagnosis and Therapy, and Translational Gastrointestinal Cancer.